Bristol-Myers Squibb Co

ConvaTec owners appoint banks to explore sale

ConvaTec's owners have appointed Morgan Stanley (MS.N) and Goldman Sachs (GS.N) to explore a sale of the medical device maker which could be worth up to $10 billion, sources familiar with the matter said.

Read Full Article

Bristol-Myers sues Merck over U.S. immunotherapy patent

Bristol-Myers Squibb Co on Thursday filed a lawsuit against Merck & Co Inc for allegedly infringing its immunotherapy patent. The company is seeking unspecified damages.

Read Full Article

Bristol-Myers to sell stake in diabetes joint venture to AstraZeneca for $3B

Bristol-Myers Squibb is reportedly exiting its stake in a diabetes joint venture with AstraZeneca for $3 billion. Bristol-Myers shifted its focus from producing diabetes and hepatitis C treatment drugs to medicines harnessing the immune system to fight cancer.

Read Full Article

Subscribe to VCpost newsletter

Sign up for our Deals of the Day newsletter.
We will not spam you!

Real Time Analytics